News & Views
Protein plays 'surprising' role in cancer
Nov 07 2011
Neil Clark
Scientists have made a discovery that could lead to possible personalised treatment of brain tumours.
In a study in the journal Nature, researchers at the University of Texas MD Anderson Cancer Center revealed that although mbryonic enzyme pyruvate kinase M2 (PKM2) has a well-known role in metabolism and human cancers, it could also play a part in cancer formation.
"Our research shows that although PKM2 plays an important role in cancer metabolism, this enzyme also has an unexpected pivotal function – it regulates cell proliferation directly," said senior author Dr Zhimin Lu, associate professor in the Department of Neuro-Oncology at MD Anderson.
He added that the fact that PKM2 contributes directly to gene transcription for cell growth was a very "surprising" finding.
Current epidermal growth factor receptor-based therapy is not very efficient, Dr Lu explained, so this discovery is important to the development of more personalised cancer treatments.
Recently, a University of Michigan Health System laboratory study also identified a possible treatment for sickle cell disease.
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
Apr 28 2024 Montreal, Quebec, Canada
May 05 2024 Seville, Spain
InformEx Zone at CPhl North America
May 07 2024 Pennsylvania, PA, USA
May 14 2024 Oklahoma City, OK, USA
May 15 2024 Birmingham, UK